Omeros Gains 32% As It Receives $200 Mln Milestone Payment

Shares of Omeros Corporation (OMER) are gaining over 32% on Monday morning after the company said it received $200 million milestone payment from Rayner Surgical.

OMER is currently trading at $4.1000, up $1.0100 or 32.6861%, on the Nasdaq, on a huge volume of 7.2 million shares, above average volume of 0.5 million. The stock opened its trading at $4.1000 after closing previous day's trading at $3.0900. The stock hast traded between $1.7400 and $7.7500 in the past 52-week period.

Omeros announced that Rayner Surgical paid the $200 million milestone payment related to the sale of Omeros's ophthalmology product Omidria to Rayner in December 2021.

Rayner will continue to pay Omeros royalties on both U.S. and ex-U.S. net sales of Omidria.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Intelligent Investor.
Follow RTT